Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2023-10-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• \[Is there any difference in the spectral range of EEG between POD patients and non POD patients\] Participants will \[Cognitive.•Postoperative delirium.•Preoperative weakness.\]
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electroencephalogram Characteristics of Surgical Anesthetized Patients and Postoperative Dilirium
NCT06394778
Intraoperative EEG Monitoring and Postoperative Delirium in Elderly Patients With Sevoflurane Anesthesia
NCT04292561
Correlation Between Perioperative EEG Features and Delirium After General Anesthesia
NCT06082024
Preoperative Cognitive Impairment Predicts Postoperative Delirium
NCT05798767
Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery
NCT04832568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
• \[Is there any difference in the spectral range of EEG between POD patients and non POD patients\] Participants will \[Sedline EEG monitoring electrodes were placed 1cm above the eyebrows on both sides of the patient and at the temples on both sides, and were continuously monitored from the start of anesthesia in the operating room until the end of the surgery.Pay close attention to the vital signs and wait for the patient to fully recover and the vital signs to basically return to the preoperative level before returning to the ward.•Assessment of cognitive function using the Mini Mental State Scale (MMSE) 1 day before surgery and 7 days after surgery.•Preoperative assessment of frailty using the frailty screening scale.•Assess delirium using the ICU Patient Ambiguity Assessment Form (CAM-ICU) 1 day, 2 days, 3 days, and 7 days after surgery.\].
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-delirious group
No postoperative delirium occurred
No interventions assigned to this group
Delirious group
Postoperative delirium occurs
delirium
Evaluation of delirium using the ICU Patient Ambiguity Assessment Form (CAM-ICU) 1 day, 2 days, 3 days, and 7 days after surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
delirium
Evaluation of delirium using the ICU Patient Ambiguity Assessment Form (CAM-ICU) 1 day, 2 days, 3 days, and 7 days after surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The preoperative Frailty Scale (FRAIL) assessed frailty
* The patient or his/her family is informed about the study and signs an informed consent form
Exclusion Criteria
* Those with a history of psychiatric or neurological illness, long-term use of psychotropic drug
* History of cerebrovascular disease, brain trauma, or surgery
* The patient was allergic to coupler or unable to place electrodes on the head
* The patient was unable to complete the scale assessment as required.Patients with severe attention to hearing impairment were unable to complete the interview
* The patient was diagnosed with delirium before surgery
65 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhuo Liu
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhuo Liu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Qinshuang Liu, master
Role: STUDY_DIRECTOR
The First hosptial of Qinhuangdao
Zhaoheng Li, master
Role: STUDY_CHAIR
The First hosptial of Qinhuangdao
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The first hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
lzh123456
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.